Concepedia

Publication | Closed Access

A randomized trial comparing 4.8 vs. 2.4g/day of oral mesalazine for maintenance of remission in ulcerative colitis

DOI

30

Citations

19

References

2015

Year

Roberta Pica, C. Cassieri, Andrea Cocco, Maddalena Zippi, Adriana Marcheggiano, Daniela De Nitto, E.V. Avallone, Pietro Crispino, G Occhigrossi, P. Paoluzi
Digestive and Liver Disease

References

YearCitations

Page 1